.jpg)
| Characteristics | Overall (n=117) |
PTB patients with DM (n=65) | PTB patients without DM (n=52) | OR (95% of CI) |
P-value | |
| Gender | Male | 84 (71.7%) | 47 (40.1%) | 37 (31.6%) | 1.06 (0.47-2.38) | 0.890 |
| Female | 33 (28.3%) | 18 (15.4%) | 15 (12.9%) | 0.95 (0.42-2.13) | ||
| Age in years | 18-25 | 10 (8.5%) | 4 (3.5%) | 6 (5.1%) | 0.56 (0.15-2.11) | 0.165 |
| 26-35 | 11 (9.4%) | 6 (5.1%) | 5 (4.3%) | 1.07 (0.31-3.73) | ||
| 36-45 | 17 (14.5%) | 11 (9.4%) | 6 (5.1%) | 1.76 (0.60-5.13) | ||
| 46-55 | 21(17.9%) | 12 (10.3%) | 9 (7.6%) | 1.23 (0.47-3.18) | ||
| 56-65 | 35 (29.9%) | 22 (33.8%) | 13 (25%) | 1.78 (0.79-4.00) | ||
| 66-75 | 23 (19.7%) | 7 (10.7%) | 16 (30.8%) | 0.31 (0.12-0.83) | ||
| Median (IQR) Age, years | 56 (38.7-62) years | |||||
| Body Mass Index (BMI) | Under weight (<18.4 kg/m²) | 45 (38.5%) | 6 (5.1%) | 39 (33.3%) | 0.03 (0.01-0.09) | 2.325 |
| Normal (18.5 kg/m² –24.9 kg/m²) | 23 (19.6%) | 13 (11.2%) | 10 (8.5%) | 1.05 (0.42-2.63) | ||
| Overweight (25 kg/m² – 29.9 kg/m²) | 37 (31.7%) |
34 (29.1%) | 3 (2.5%) | 17.91 (5.06-63.36) | ||
| Obese (>30 kg/m²) | 12 (10.2%) | 12 (10.3%) | 0 (0%) | - | ||
| Other Underlying Conditions n (%) | Hypertension | 22 (18.8%) | 19 (16.2%) | 3 (2.6%) | 4.86 (1.28-18.42) | 0.114 |
| Cardiovascular disease | 3 (2.5%) | 2 (1.7%) | 1 (0.8%) | 1.06 (0.09-12.32) | ||
| Chronic Kidney Disease | 9 (7.6%) | 6 (5.1%) | 3 (2.6%) | 1.07 (0.24-4.68) | ||
| Airway disease | 30 (25.6%) | 15 (12.8%) | 15 (12.8%) | 0.32 (0.12-0.87) | ||
| Cirrhosis | 2 (1.7%) | 0 (%) | 2 (1.7%) | NA | ||
| Autoimmune disease | 1 (0.8%) | 1 (0.8%) | 0 (%) | NA | ||
| HIV | 1 (0.8%) | 1 (0.8%) | 0 (%) | NA | ||
| HBsAg | 2 (1.7%) | 1 (0.8%) | 1 (0.8%) | 0.52 (0.03-8.68) | ||
| Coronary Artery Disease | 5 (4.3%) | 4 (3.4%) | 1 (0.8%) | 2.22(0.24-20.98) | ||
| Symptoms n (%) | Cough | 104(88.9%) | 59 (50.4%) | 45 (38.5%) | 2.98 (1.38-6.69) | 0.536 |
| Fever | 72 (61.5%) | 41 (35%) | 31 (26.5%) | 1.78 (0.91-3.48) | ||
| Weight loss | 65 (55.6%) | 39 (33.3%) | 26 (22.2%) | 2.13 (1.08-4.19) | ||
| Breathlessness | 50 (42.7%) | 23 (19.7%) | 27 (23.1%) | 0.78(0.39-1.56) | ||
| Hemoptysis | 20 (17.1%) | 14 (12%) | 6 (5.1%) | 2.67(0.96-7.41) | ||
| Chest discomfort | 56 (47.9%) | 28 (23.9%) | 28 (23.9%) | 1.00(0.51-1.97) | ||
| Vomiting | 13 (11.1%) | 8 (6.8%) | 5 (4.3%) | 1.68(0.58-5.41) | ||
| Habits n (%) | Smoking | 40 (34.2%) | 23 (19.7%) | 17 (14.5%) | 1.53(0.73-3.20) | 0.962 |
| Alcohol | 30 (25.6%) | 16 (13.7%) | 14 (12%) | 1.19(0.53-2.66) | ||
| Tobacco chewing | 3 (2.6%) | 2 (1.7%) | 1 (0.8%) | 2.03(0.18-22.91) | ||
| No habits | 44 (37.6%) | 24 (20.5%) | 20 (17.1%) | 1.30(0.64-2.67) | ||
| Hemoglobin levels g/dL n (%) | Severe anemia (<7 g/dL) | 3 (2.6%) | 0 (0%) | 3 (2.6%) | 0.05(0.00-1.14) | 0.018* |
| Mild to moderate anemia (7±12.9 g/dL) | 87 (74.3%) | 45 (38.5%) | 42 (35.9%) | 0.37(0.14-0.98) | ||
| Normal (>13 g/dL) | 27 (23.2%) | 20 (17.1%) | 7 (5.9%) | 2.85(1.10-7.39) | ||
| Characteristics | Overall (n=117) |
PTB Patients with DM (n=65) | PTB Patients without DM (n=52) | OR (95% of CI) |
P-value | |
| Sputum Study, (n%) | CBNAAT | 99 (84.6%) | 59 (50.4%) | 40 (34.2%) | 2.16 (1.21-3.86) |
0.1696 |
| Rifampicin resistance | 14 (12%) | 5 (4.3%) | 9 (7.6%) | 0.31 (0.08-1.14) |
||
| AFB Positive | 39 (33.4%) | 25 (21.4%) | 14 (12%) | 1.36 (0.63-2.91) |
||
| Radiological Findings (n%) | Upper lung zone lesion | 18 (15.4%) | 11 (9.4%) | 7 (5.9%) | 1.06 (0.37-3.05) |
0.0032* |
| Lower lung zone lesion | 27 (23.1%) | 23 (19.7%) | 4 (3.4%) | 5.88 (1.88-18.3) |
||
| Consolidation | 50 (42.7%) | 30 (25.6%) | 20 (17.1%) | 1.52 (0.68-3.37) |
||
| Cavity lesion | 11 (9.4%) | 9 (7.6%) | 2 (1.7%) | 3.05 (0.60-15.6) |
||
| Pleural effusion | 12 (10.3%) | 3 (2.5%) | 9 (7.6%) | 0.18 (0.04-0.77) |
||
| Tree-in-bud sign | 39 (33.3%) | 22 (18.8%) | 17 (14.5%) | 0.93 (0.42-2.05) |
||
| Cavity lesion with Consolidation | 10 (8.6%) | 7 (5.9%) |
3 (2.5%) | 1.62 (0.38-6.92) |
||
| Bronchiectasis | 3 (2.5%) | 2 (1.7%) | 1 (0.8%) | 1.37 (0.12-15.1) |
||
| Calcified granuloma | 2 (1.7%) | 0 (0%) | 2 (1.7%) | NA | ||
| Characteristics | Overall (n=117) |
PTB Patients with DM (n=65) | PTB Patients without DM (n=52) | |
| Distribution of Glycated hemoglobin (HbA1c) levels | Normoglycemia - ≤ 5.6% | 52 (44.5%) | 0 (0%) | 52 (100%) |
| Prediabetes - 5.7% – 6.4% | 4 (3.4%) | 4 (6.2%) | 0 (0%) | |
| Diabetes (T2DM) - ≥ 6.5% | 61 (52.1%) | 61 (93.8%) | 0 (0%) | |
| Distribution of HbA1c levels among Male PTB patients (n=84) | Normoglycemia - ≤ 5.6% | 34 (29.1%) | 0 (0%) | 34 (65.4%) |
| Prediabetes - 5.7% – 6.4% | 3 (2.4%) | 3 (4.6%) | 0 (0%) | |
| Diabetes (T2DM) - ≥ 6.5% | 47 (40.2%) | 47 (72.4%) | 0 (0%) | |
| Distribution of HbA1c levels among Female PTB patients (n=33) | Normoglycemia - ≤ 5.6% | 18 (15.3%) | 0 (0%) | 18 (34.6%) |
| Prediabetes - 5.7% – 6.4% | 1 (0.9%) | 1 (1.5%) | 0 (0%) | |
| Diabetes (T2DM) - ≥ 6.5% | 14 (11.9%) | 14 (21.5%) | 0 (0%) | |
| Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution 4.0 International License. |